Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of OSI Pharmaceuticals patents

Patents where

Current Assignee

Name

‌

OSI Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7939272 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors	Patent 7939272 was granted and assigned to OSI Pharmaceuticals on May, 2011 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7939272	May 10, 2011
‌ US Patent 7144711 AGS proteins and nucleic acid molecules and uses therefor	Patent 7144711 was granted and assigned to OSI Pharmaceuticals on December, 2006 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7144711	December 5, 2006
‌ US Patent 7951549 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation	Patent 7951549 was granted and assigned to OSI Pharmaceuticals on May, 2011 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7951549	May 31, 2011
‌ US Patent 6900221 Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof	Patent 6900221 was granted and assigned to OSI Pharmaceuticals on May, 2005 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	6900221	May 31, 2005
‌ US Patent 8101613 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors	Patent 8101613 was granted and assigned to OSI Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	8101613	January 24, 2012
‌ US Patent 7923555 Fused bicyclic mTor inhibitors	Patent 7923555 was granted and assigned to OSI Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7923555	April 12, 2011
‌ US Patent 7087613 Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride	Patent 7087613 was granted and assigned to OSI Pharmaceuticals on August, 2006 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7087613	August 8, 2006
‌ US Patent 8735405 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors	Patent 8735405 was granted and assigned to OSI Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	8735405	May 27, 2014
‌ US Patent 8314111 Fused bicyclic motor inhibitors	Patent 8314111 was granted and assigned to OSI Pharmaceuticals on November, 2012 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	8314111	November 20, 2012
‌ US Patent 8399433 Amino pyrimidine anticancer compounds	Patent 8399433 was granted and assigned to OSI Pharmaceuticals on March, 2013 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	8399433	March 19, 2013
‌ US Patent 7160890 Compounds specific to adenosine A	Patent 7160890 was granted and assigned to OSI Pharmaceuticals on January, 2007 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7160890	January 9, 2007
‌ US Patent 7459554 Imidazopyrazine tyrosine kinase inhibitors	Patent 7459554 was granted and assigned to OSI Pharmaceuticals on December, 2008 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7459554	December 2, 2008
‌ US Patent 7485658 N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors	Patent 7485658 was granted and assigned to OSI Pharmaceuticals on February, 2009 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7485658	February 3, 2009
‌ US Patent 8022206 Furo[3,2-C]pyridines	Patent 8022206 was granted and assigned to OSI Pharmaceuticals on September, 2011 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	8022206	September 20, 2011
‌ US Patent 9351974 Substituted pteridinones for the treatment of cancer	Patent 9351974 was granted and assigned to OSI Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.	‌ OSI Pharmaceuticals	‌ OSI Pharmaceuticals	United States Patent and Trademark Office	9351974	May 31, 2016
‌ US Patent 7767673 N-substituted imidazopyridine c-Kit inhibitors	Patent 7767673 was granted and assigned to OSI Pharmaceuticals on August, 2010 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7767673	August 3, 2010
‌ US Patent 7829717 (Arylamidoaryl)squaramide compounds	Patent 7829717 was granted and assigned to OSI Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7829717	November 9, 2010
‌ US Patent 7648987 Bicyclic protein kinase inhibitors	Patent 7648987 was granted and assigned to OSI Pharmaceuticals on January, 2010 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7648987	January 19, 2010
‌ US Patent 7524859 (2-carboxamido)(3-amino)thiophene compounds	Patent 7524859 was granted and assigned to OSI Pharmaceuticals on April, 2009 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7524859	April 28, 2009
‌ US Patent 11253520 Pulse dosing regimen and methods of treatment	Patent 11253520 was granted and assigned to OSI Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.	‌ OSI Pharmaceuticals	‌ OSI Pharmaceuticals	United States Patent and Trademark Office	11253520	February 22, 2022
‌ US Patent 7696225 (2-carboxamido)(3-Amino) thiophene compounds	Patent 7696225 was granted and assigned to OSI Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7696225	April 13, 2010
‌ US Patent 7115647 Method of inhibiting neoplastic cells with indole derivatives	Patent 7115647 was granted and assigned to OSI Pharmaceuticals on October, 2006 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7115647	October 3, 2006
‌ US Patent 7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use	Patent 7429574 was granted and assigned to OSI Pharmaceuticals on September, 2008 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7429574	September 30, 2008
‌ US Patent 7662844 Naphthylene derivatives as cytochrome P450 inhibitors	Patent 7662844 was granted and assigned to OSI Pharmaceuticals on February, 2010 by the United States Patent and Trademark Office.		‌ OSI Pharmaceuticals	United States Patent and Trademark Office	7662844	February 16, 2010
‌ US Patent 10583142 Pulse dosing regimen and methods of treatment	Patent 10583142 was granted and assigned to OSI Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office.	‌ OSI Pharmaceuticals	‌ OSI Pharmaceuticals	United States Patent and Trademark Office	10583142	March 10, 2020

Results per page:

84 results

0 selected

84 results

0 selected